Authors

• Cyril Llamoso
• Hadas Dvory‐Sobol (ORCID: https://orcid.org/0000-0003-0716-2750)
• Ronald Nahass (ORCID: https://orcid.org/0000-0002-4401-7491)
• Mezgebe Berhe (ORCID: https://orcid.org/0000-0002-7287-567X)
• Afsoon Roberts
• Amy E. Colson
• Stephanie O. Klopfer
• Elizabeth G. Rhee (ORCID: https://orcid.org/0000-0001-7982-1714)
• Shanyu Liu (ORCID: https://orcid.org/0000-0002-5787-2251)
• Jared M. Baeten (ORCID: https://orcid.org/0000-0001-8242-8438)
• Sharline Madera (ORCID: https://orcid.org/0000-0003-3658-5488)
• Alexandra W. Dretler (ORCID: https://orcid.org/0000-0003-2825-4988)
• Shauna Applin (ORCID: https://orcid.org/0009-0005-1980-2649)
• Kimberly Workowski (ORCID: https://orcid.org/0000-0002-9918-9493)
• Peter Ruane (ORCID: https://orcid.org/0000-0002-7170-9928)
• F. Shihadeh
• Martin S. Rhee (ORCID: https://orcid.org/0000-0001-5263-9613)
• Cynthia Brinson
• DT Jayaweera
• Gary I. Sinclair
• Joseph J. Eron
• Gordon E. Crofoot
• Moti N. Ramgopal

Institutions

• University of North Carolina at Chapel Hill (US)
• Cambridge Health Alliance (US)
• Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
• University of Miami (US)
• Emory University (US)
• George Washington University (US)
• Hillsborough Hospital (CA)
• Infectious Disease Consultants (US)
• Community Care (US)
• VA North Texas Health Care System (US)
• Gilead Sciences (United States) (US)
• Ruane Medical (US)
• Generation 2 Materials Technology (United States) (US)
• Tacoma Community College (US)
• Indian River State College (US)
• Texas A&M University – Central Texas (US)

Publication Details

Journal

Annals of Internal Medicine

Published

2025-12-22

DOI

https://doi.org/10.7326/annals-25-01939

Primary Topic

HIV/AIDS drug development and treatment

Type

article

Field-Weighted Citation Impact

0.00